TY - JOUR
T1 - Role of Antiplatelet/Anticoagulant Medications and Blood-Clotting Tests in Prediction of Traumatic Foot Compartment Syndrome
AU - Park, Young Hwan
AU - Choi, Won Seok
AU - Choi, Gi Won
AU - Kim, Hak Jun
N1 - Publisher Copyright:
© 2018, © The Author(s) 2018.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7%) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.
AB - Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7%) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.
KW - anticoagulant
KW - antiplatelet
KW - blood-clotting test
KW - foot compartment syndrome
UR - http://www.scopus.com/inward/record.url?scp=85044055239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044055239&partnerID=8YFLogxK
U2 - 10.1177/1071100718757956
DO - 10.1177/1071100718757956
M3 - Article
C2 - 29506396
AN - SCOPUS:85044055239
VL - 39
SP - 725
EP - 730
JO - Foot and Ankle International
JF - Foot and Ankle International
SN - 1071-1007
IS - 6
ER -